The nonpsychoactive cannabis constituent cannabidiol is an oral anti-arthritic therapeutic in murine collagen-induced arthritis.
Subject: Arthritis - PUBLISHED VIA Proceedings of the National Academy of Sciences of the United States of America
Author(s):
Malfait AM, Gallily R, Sumariwalla PF, Malik AS, Andreakos E, Mechoulam R, Feldmann M
View Source >>
Related Studies:
The abnormal cannabidiol analogue O-1602 reduces nociception in a rat model of acute arthritis via the putative cannabinoid receptor GPR55.
Published via Neuroscience Letters
Preliminary assessment of the efficacy, tolerability and safety of a cannabis-based medicine (Sativex) in the treatment of pain caused by rheumatoid arthritis.
Published via Rheumatology
Involvement of the endocannabinoid system in osteoarthritis pain.
Published via European Journal of Neuroscience